Literature DB >> 26646933

A luminescent europium(III)-platinum(II) heterometallic complex as a theranostic agent: a proof-of-concept study.

Anirban Chandra1, Khushbu Singh1, Swati Singh2, Sri Sivakumar2, Ashis K Patra1.   

Abstract

A luminescent heterometallic multifunctional theranostic Eu-Pt2 complex [{cis-PtCl2(DMSO)}2Eu(L)(H2O)] has been synthesized, possessing two therapeutic Pt-centers as covalent DNA binders and one emissive Eu(3+)-center which is sensitized by platinum-based metal-to-ligand charge-transfer excited states.

Entities:  

Year:  2016        PMID: 26646933     DOI: 10.1039/c5dt04470g

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  4 in total

1.  Luminescent bis(benzo[d]thiazolyl)quinoxaline: facile synthesis, nucleic acid and protein BSA interaction, live-cell imaging, biopharmaceutical research and cancer theranostic application.

Authors:  Lavanya Thilak Babu; Gajanan Raosaheb Jadhav; Priyankar Paira
Journal:  RSC Adv       Date:  2019-03-18       Impact factor: 4.036

Review 2.  Challenges and opportunities in the development of metal-based anticancer theranostic agents.

Authors:  Shreyas P Vaidya; Shubhankar Gadre; Ravi Teja Kamisetti; Malay Patra
Journal:  Biosci Rep       Date:  2022-05-27       Impact factor: 3.840

3.  DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2',3'-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction.

Authors:  Aleksandar Savić; Anna M Kaczmarek; Rik Van Deun; Kristof Van Hecke
Journal:  Molecules       Date:  2020-11-13       Impact factor: 4.411

4.  Luminescent Bimetallic IrIII /AuI Peptide Bioconjugates as Potential Theranostic Agents.

Authors:  Andrés Luengo; Isabel Marzo; Matthew Reback; Isabelle M Daubit; Vanesa Fernández-Moreira; Nils Metzler-Nolte; M Concepción Gimeno
Journal:  Chemistry       Date:  2020-09-02       Impact factor: 5.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.